Results 111 to 120 of about 577,308 (213)

JAK2 V617F Mutation and Large Cerebral Artery Disease in Patients with Myeloproliferative Neoplasms. [PDF]

J Atheroscler Thromb, 2023
Oyama N, Iwamoto T, Doyu K, Miyazato S, Okazaki T, Yamada S, Kondo T, Wada H, Yagita Y.   +8 more
europepmc   +1 more source

Kaplan Meier estimate of cumulative probability of blast transformation (BT) in the three genotypes for JAK2V617F mutation.

, 2013
Kaplan Meier estimate of cumulative probability of blast transformation (BT) in the three genotypes for JAK2V617F mutation.
Margherita Massa (133323), Valentina Poletto (325692), Paolo Catarsi (325689), Catherine Klersy (394687), Rita Campanelli (325687), Giovanni Barosi (325686), Laura Villani (10719), Gianluca Viarengo (325693), Elisa Bonetti (133296), Vittorio Rosti (133339)   +9 more
core   +1 more source

Jak2 46/1 Haplotype Is Associated With Jak2 V617f--positive Myeloproliferative Neoplasms In Brazilian Patients.

, 2016
This study aimed to verify the association between the JAK2 46/1 haplotype (V617F positive) and some hematological parameters in BCR-ABL-negative chronic myeloproliferative neoplasms (cMPNs) in our population. The blood samples obtained from the patients
L. C.; Santos, K. B. B.; Rodrigues, Ambrosio-Albuquerque, E P, Sell, A M, Pagliarini-e-Silva, S, Macedo, F. C.; Ferreira, E. C.; Ambrosio-Albuquerque, Visentainer, J E L, Santos, B C, J. E. L., S.; Pagnano, A. M.; Visentainer, Ferreira, M E, E. P.; Sell, Rodrigues, C, Quintero, F C, Macedo, L C, M. E.; Baraldi, Baraldi, E C, C.; Quintero, B. C.; Pagliarini-E-Silva, Pagnano, K B B   +22 more
core   +1 more source

THE JAK2 V617F MUTATION IN LUNG CANCER: CAVEAT EMPTOR

Experimental Oncology, 2018
As acquisition of the JAK2 V6 7F is considered to e restricted to myeloid malignancies the recurrent identification of this mutation in non-small cell lung cancer NSCLC merits discussion particularly in the light of accumulating evidence which suggests that the JAK2 V6 7F may not e a true driver mutation of NSCLC.
openaire   +2 more sources

JAK2-V617F Mutation is Associated with Clinical and Laboratory Features of Myeloproliferative Neoplasms [PDF]

, 2012
The aim of this study is to investigate the differences of clinical and laboratory parameters between patients with JAK2-V617F positive myeloproliferative neoplasms (MPNs) and JAK2 wild type MPNs.
Hadžisejdić, Ita, Kušen, Ivona, Načinović Duletić, Antica, Matušan Ilijaš, Koviljka, Dekanić, Andrea, Grohovac, Dragana, Jonjić, Nives, Grahovac, Blaženka   +7 more
core  

JAK2 V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes. [PDF]

Blood Adv, 2023
Rafati M, Brown DW, Zhou W, Jones K, Luo W, St Martin A, Wang Y, He M, Spellman SR, Wang T, Deeg HJ, Gupta V, Lee SJ, Bolon YT, Chanock SJ, Machiela MJ, Saber W, Gadalla SM.   +17 more
europepmc   +1 more source

JAK2 V617F/C618R mutation in a patient with polycythemia vera: a case study and review of the literature

, 2009
The acquired Janus kinase 2 (JAK2) V617F mutation shows a high frequency in diverse BCR/ABL-negative chronic myeloproliferative disorders (CMPD), and it is typically associated with polycythemia vera (PV). The frequency of JAK2 V617F mutation is about 90%
박태성, 선영규, 이경아, 송재우, 최종락   +4 more
core   +1 more source

The JAK2 V617F mutation and thrombocytopenia

Hematology/Oncology and Stem Cell Therapy, 2017
Langabeer, Stephen E., Haslam, Karl
openaire   +2 more sources

Absence of JAK2 V617F mutation in gastric cancers [PDF]

Acta Oncologica, 2006
Jong Woo, Lee, Young Hwa, Soung, Su Young, Kim, Suk Woo, Nam, Won Sang, Park, Jung Young, Lee, Nam Jin, Yoo, Sug Hyung, Lee   +7 more
openaire   +2 more sources

Oral squamous cell carcinoma with essential thrombocythemia and positive JAK2 (V617F) mutation. [PDF]

J Taibah Univ Med Sci, 2022
Rahman KH, Surboyo MDC, Radithia D, Parmadiati AE, Wihandono A, Ernawati DS.   +5 more
europepmc   +1 more source